Patients with age-related macular degeneration face a future with only one certainty – to retain their sight, they will need injections directly into their eye ball at 6 to 12 weekly intervals. It’s not usually painful, but it is uncomfortable and it’s a procedure that involves some risk in terms of nasty infections and other unwanted effects. Most patients would prefer not to have to undergo the procedure at all. But the alternative is unacceptable. However, we can make a lifetime of injections a little bit easier by extending the time between procedures. With Lucentis, you can give their eyes a break.